Author: DAEWOONG PHARMACEUTICAL

Posted Date:

April 7, 2026

CGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results

DAEWOONG PHARMACEUTICAL

April 7, 2026
CGBIO Showcases Minimally Invasive Spine Surgery Techniques in Thailand: “Smaller Incisions, Faster Recovery”

DAEWOONG PHARMACEUTICAL

March 30, 2026